AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] C.H. Robinson Worldwide, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.

Rajan Arun, Chief Strategy & Innovation Officer di C.H. Robinson Worldwide, Inc. (CHRW), ha venduto 2.500 azioni ordinarie il 15/08/2025 al prezzo di $121,74 per azione. La comunicazione indica che la cessione è avvenuta in base a un piano 10b5-1(c) adottato il 08/05/2025. Dopo l’operazione, la persona segnalante detiene beneficiariamente 130.591 azioni, comprensive di 91.210 azioni che saranno attribuite alla liquidazione di restricted stock units e di azioni differite accreditate su un conto del piano NQDC, e di 38.994 azioni detenute direttamente; ulteriori 387 azioni sono state acquisite tramite il piano di acquisto azionario per dipendenti. Il modulo è firmato da un procuratore e contiene esclusivamente la transazione dell’insider e la ripartizione della proprietà sopra indicata.

Rajan Arun, Chief Strategy & Innovation Officer de C.H. Robinson Worldwide, Inc. (CHRW), vendió 2.500 acciones ordinarias el 15/08/2025 a $121,74 por acción. La presentación señala que la venta se realizó conforme a un plan 10b5-1(c) adoptado el 08/05/2025. Tras la operación, la persona que informa posee de forma beneficiaria 130.591 acciones, que incluyen 91.210 acciones que se entregarán al vencimiento de unidades de acciones restringidas y acciones diferidas acreditadas en una cuenta del plan NQDC, y 38.994 acciones mantenidas directamente; además, se adquirieron 387 acciones adicionales mediante el plan de compra de acciones para empleados. El formulario está firmado por un apoderado y sólo contiene la operación del insider y el desglose de la propiedad arriba indicado.

Rajan Arunì€ C.H. Robinson Worldwide, Inc.(CHRW)ì� 최고 전략·í˜ì‹  ì±…ìž„ìžë¡œì„� 2025-08-15ì—� 보통ì£� 2,500주를 주당 $121.74ì—� 매ë„했다ê³� 보고했습니다. 제출서류ì—� 따르ë©� 해당 매ê°ì€ 2025-05-08ì—� 채íƒë� 10b5-1(c) 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�. ë³´ê³ ë� 거래 í›� 해당 ë³´ê³ ì¸ì€ ì´� 130,591주를 실질ì ìœ¼ë¡� 보유하고 있으ë©�, ì´ëŠ” 제한ì£� 단위ì� ì •ì‚° ë°� NQDC 플랜 계정ì—� ì ë¦½ë� ì´ì—° 주ì‹ìœ¼ë¡œ ì§€ê¸‰ë  91,210주와 ì§ì ‘ 보유í•� 38,994주를 í¬í•¨í•©ë‹ˆë‹�; 추가ë¡� ì§ì› ì£¼ì‹ ë§¤ìž… 계íšì� 통해 387주가 ì·¨ë“ë˜ì—ˆìŠµë‹ˆë‹�. 서류ëŠ� 대리ì¸ì� 서명했으ë©� ìœ„ì— ê¸°ìž¬ë� ë‚´ë¶€ìž� 거래 ë°� 보유 ë‚´ì—­ë§Œì„ ë‹´ê³  있습니다.

Rajan Arun, Chief Strategy & Innovation Officer de C.H. Robinson Worldwide, Inc. (CHRW), a déclaré la vente de 2�500 actions ordinaires le 15/08/2025 au prix de 121,74 $ par action. Le dépôt précise que la vente a été effectuée en vertu d’un plan 10b5-1(c) adopté le 08/05/2025. Après cette opération, la personne déclarant détient bénéficiairement 130�591 actions, comprenant 91�210 actions à attribuer lors du règlement d’unités d’actions restreintes et d’actions différées créditées sur un compte du plan NQDC, ainsi que 38�994 actions détenues directement ; 387 actions supplémentaires ont été acquises via le plan d’achat d’actions des employés. Le formulaire est signé par un mandataire et ne contient que la transaction d’initié et la ventilation de la détention indiquées ci‑dessus.

Rajan Arun, Chief Strategy & Innovation Officer von C.H. Robinson Worldwide, Inc. (CHRW), meldete den Verkauf von 2.500 Stammaktien am 15.08.2025 zu einem Preis von $121,74 je Aktie. In der Meldung heißt es, der Verkauf erfolgte im Rahmen eines am 08.05.2025 verabschiedeten 10b5-1(c)-Plans. Nach der gemeldeten Transaktion besitzt die meldepflichtige Person wirtschaftlich 130.591 Aktien, darunter 91.210 Aktien, die bei Abrechnung von Restricted Stock Units und als auf ein NQDC-Plan-Konto gutgeschriebene aufgeschobene Aktien zugeteilt werden, sowie 38.994 direkt gehaltene Aktien; ferner wurden 387 Aktien über den Mitarbeiteraktienkaufplan erworben. Das Formular ist von einem Bevollmächtigten unterzeichnet und enthält ausschließlich die oben genannten Insider-Transaktion und die Eigentumsaufstellung.

Positive
  • Transaction executed under a documented 10b5-1 plan adopted 05/08/2025, indicating pre-planned trading and compliance with insider trading procedures
  • Substantial remaining ownership of 130,591 shares, largely composed of restricted stock units and deferred shares, which supports ongoing alignment with shareholder interests
Negative
  • Officer sold 2,500 shares on 08/15/2025 at $121.74 per share; while disclosed, the filing does not provide context on whether the sale affects compensation or diversification plans

Insights

TL;DR Insider sale of 2,500 shares under a 10b5-1 plan; substantial remaining ownership of 130,591 shares maintains alignment with shareholders.

The sale recorded on 08/15/2025 at $121.74 per share was executed under a documented 10b5-1 plan adopted 05/08/2025, which indicates pre-planned disposition rather than opportunistic trading. Post-transaction beneficial ownership of 130,591 shares includes a large portion held in restricted stock units and deferred compensation, suggesting continued long-term exposure to company equity. The transaction size (2,500 shares) is small relative to the reported total holdings and does not, by itself, indicate a material change in insider alignment.

TL;DR Use of a formal 10b5-1 plan and attorney-in-fact signature reflects procedural compliance and documentation of the insider trade.

The filing documents adoption of a 10b5-1(c) trading plan on 05/08/2025 and a transaction completed under that plan on 08/15/2025. The signature by an attorney-in-fact is consistent with delegated execution. The disclosure of amounts held in restricted stock units, deferred accounts, and ESPP shares provides transparent reporting of indirect and direct ownership. From a governance perspective these elements indicate adherence to standard insider trading controls and disclosure practices.

Rajan Arun, Chief Strategy & Innovation Officer di C.H. Robinson Worldwide, Inc. (CHRW), ha venduto 2.500 azioni ordinarie il 15/08/2025 al prezzo di $121,74 per azione. La comunicazione indica che la cessione è avvenuta in base a un piano 10b5-1(c) adottato il 08/05/2025. Dopo l’operazione, la persona segnalante detiene beneficiariamente 130.591 azioni, comprensive di 91.210 azioni che saranno attribuite alla liquidazione di restricted stock units e di azioni differite accreditate su un conto del piano NQDC, e di 38.994 azioni detenute direttamente; ulteriori 387 azioni sono state acquisite tramite il piano di acquisto azionario per dipendenti. Il modulo è firmato da un procuratore e contiene esclusivamente la transazione dell’insider e la ripartizione della proprietà sopra indicata.

Rajan Arun, Chief Strategy & Innovation Officer de C.H. Robinson Worldwide, Inc. (CHRW), vendió 2.500 acciones ordinarias el 15/08/2025 a $121,74 por acción. La presentación señala que la venta se realizó conforme a un plan 10b5-1(c) adoptado el 08/05/2025. Tras la operación, la persona que informa posee de forma beneficiaria 130.591 acciones, que incluyen 91.210 acciones que se entregarán al vencimiento de unidades de acciones restringidas y acciones diferidas acreditadas en una cuenta del plan NQDC, y 38.994 acciones mantenidas directamente; además, se adquirieron 387 acciones adicionales mediante el plan de compra de acciones para empleados. El formulario está firmado por un apoderado y sólo contiene la operación del insider y el desglose de la propiedad arriba indicado.

Rajan Arunì€ C.H. Robinson Worldwide, Inc.(CHRW)ì� 최고 전략·í˜ì‹  ì±…ìž„ìžë¡œì„� 2025-08-15ì—� 보통ì£� 2,500주를 주당 $121.74ì—� 매ë„했다ê³� 보고했습니다. 제출서류ì—� 따르ë©� 해당 매ê°ì€ 2025-05-08ì—� 채íƒë� 10b5-1(c) 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�. ë³´ê³ ë� 거래 í›� 해당 ë³´ê³ ì¸ì€ ì´� 130,591주를 실질ì ìœ¼ë¡� 보유하고 있으ë©�, ì´ëŠ” 제한ì£� 단위ì� ì •ì‚° ë°� NQDC 플랜 계정ì—� ì ë¦½ë� ì´ì—° 주ì‹ìœ¼ë¡œ ì§€ê¸‰ë  91,210주와 ì§ì ‘ 보유í•� 38,994주를 í¬í•¨í•©ë‹ˆë‹�; 추가ë¡� ì§ì› ì£¼ì‹ ë§¤ìž… 계íšì� 통해 387주가 ì·¨ë“ë˜ì—ˆìŠµë‹ˆë‹�. 서류ëŠ� 대리ì¸ì� 서명했으ë©� ìœ„ì— ê¸°ìž¬ë� ë‚´ë¶€ìž� 거래 ë°� 보유 ë‚´ì—­ë§Œì„ ë‹´ê³  있습니다.

Rajan Arun, Chief Strategy & Innovation Officer de C.H. Robinson Worldwide, Inc. (CHRW), a déclaré la vente de 2�500 actions ordinaires le 15/08/2025 au prix de 121,74 $ par action. Le dépôt précise que la vente a été effectuée en vertu d’un plan 10b5-1(c) adopté le 08/05/2025. Après cette opération, la personne déclarant détient bénéficiairement 130�591 actions, comprenant 91�210 actions à attribuer lors du règlement d’unités d’actions restreintes et d’actions différées créditées sur un compte du plan NQDC, ainsi que 38�994 actions détenues directement ; 387 actions supplémentaires ont été acquises via le plan d’achat d’actions des employés. Le formulaire est signé par un mandataire et ne contient que la transaction d’initié et la ventilation de la détention indiquées ci‑dessus.

Rajan Arun, Chief Strategy & Innovation Officer von C.H. Robinson Worldwide, Inc. (CHRW), meldete den Verkauf von 2.500 Stammaktien am 15.08.2025 zu einem Preis von $121,74 je Aktie. In der Meldung heißt es, der Verkauf erfolgte im Rahmen eines am 08.05.2025 verabschiedeten 10b5-1(c)-Plans. Nach der gemeldeten Transaktion besitzt die meldepflichtige Person wirtschaftlich 130.591 Aktien, darunter 91.210 Aktien, die bei Abrechnung von Restricted Stock Units und als auf ein NQDC-Plan-Konto gutgeschriebene aufgeschobene Aktien zugeteilt werden, sowie 38.994 direkt gehaltene Aktien; ferner wurden 387 Aktien über den Mitarbeiteraktienkaufplan erworben. Das Formular ist von einem Bevollmächtigten unterzeichnet und enthält ausschließlich die oben genannten Insider-Transaktion und die Eigentumsaufstellung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RAJAN ARUN

(Last) (First) (Middle)
14701 CHARLSON ROAD

(Street)
EDEN PRAIRIE MN 55347

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
C. H. ROBINSON WORLDWIDE, INC. [ CHRW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Strat & Innov Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 S(1) 2,500 D $121.74 130,591(2)(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Adoption date of referenced 10b5-1(c) plan is: 05-08-2025
2. Included in this amount are 91,210 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 38,994 shares held directly by the reporting person.
3. Includes 387 shares acquired pursuant to the Issuer's employee stock purchase plan.
/s/ Nicole Strydom, Attorney-in-Fact for Arun Rajan 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CHRW insider Rajan Arun report on Form 4?

The filing reports a sale of 2,500 shares on 08/15/2025 at $121.74 per share and shows 130,591 shares beneficially owned after the transaction.

Was the sale by Rajan Arun part of a trading plan?

Yes. The sale was reported as made pursuant to a 10b5-1(c) plan adopted on 05/08/2025.

How is the 130,591 shares of reported ownership composed?

The filing states it includes 91,210 shares issuable upon settlement of restricted stock units and deferred shares in a NQDC plan account, 38,994 shares held directly, and 387 shares acquired via the employee stock purchase plan.

What position does the reporting person hold at CHRW?

The reporting person is listed as Chief Strategy & Innovation Officer and an officer of the issuer.

Who signed the Form 4 on behalf of Rajan Arun?

The Form 4 is signed by Nicole Strydom, Attorney-in-Fact for Arun Rajan with signature date 08/19/2025.
C H Robinson Worldwide Inc

NASDAQ:CHRW

CHRW Rankings

CHRW Latest News

CHRW Latest SEC Filings

CHRW Stock Data

14.78B
117.07M
0.81%
99.08%
5.83%
Integrated Freight & Logistics
Arrangement of Transportation of Freight & Cargo
United States
EDEN PRAIRIE